Life Technologies | Lånekapital



Loan Capital Endring Dato
Ardelyx USD 150.85M 50.15M 2024-12
Biogen USD 4.55B 1.4M 2024-12
Bristol-Myers Squibb USD 47.6B 1.07B 2024-12
Cipla INR 2.18B 18.2M 2024-09
Clal Biotechnology ILS 25.96M 18.48M 2023-12
Compugen USD 0 0 2024-09
CSL USD 11.24B 552M 2024-06
Galapagos EUR 8.24M 1000K 2024-12
GlaxoSmithKline GBP 14.64B 1.39B 2024-12
Grifols EUR 8.68B 155.99M 2024-12
Life Technologies USD 1.03M 136K 2024-09
Novartis USD 22.93B 2.41B 2024-12
Roche Holding CHF 32.1B 1.94B 2024-12
United Therapeutics USD 0 0 2024-12



Life Technologies Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.